These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12549955)

  • 21. Regulated genes in psoriatic skin during treatment with fumaric acid esters.
    Onderdijk AJ; Balak DM; Baerveldt EM; Florencia EF; Kant M; Laman JD; van IJcken WF; Racz E; de Ridder D; Thio HB; Prens EP
    Br J Dermatol; 2014 Oct; 171(4):732-41. PubMed ID: 24852654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Maculopapular exanthema during diltiazem therapy].
    Hammentgen R; Lutz G; Köhler U; Nitsch J
    Dtsch Med Wochenschr; 1988 Aug; 113(33):1283-5. PubMed ID: 3409812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disseminated granuloma annulare--treatment with fumaric acid esters.
    Eberlein-König B; Mempel M; Stahlecker J; Forer I; Ring J; Abeck D
    Dermatology; 2005; 210(3):223-6. PubMed ID: 15785051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions.
    Inzinger M; Weger W; Heschl B; Salmhofer W; Quehenberger F; Wolf P
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):861-6. PubMed ID: 22672248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological changes in psoriasis patients under long-term treatment with fumaric acid esters: risk of Kaposi sarcoma occurrence?
    Philipp S; Kokolakis G; Hund M; Witte E; Witte K; Kunz S; Roewert HJ; Sterry W; Sabat R
    Eur J Dermatol; 2013; 23(3):339-43. PubMed ID: 23774790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy of noninfectious granulomatous skin diseases with fumaric acid esters.
    Breuer K; Gutzmer R; Völker B; Kapp A; Werfel T
    Br J Dermatol; 2005 Jun; 152(6):1290-5. PubMed ID: 15948995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions - a retrospective evaluation (FACTS).
    Thaçi D; Weisenseel P; Philipp S; Rosenbach T; Rotterdam S; Augustin M; Neureither M; Reich K
    J Dtsch Dermatol Ges; 2013 May; 11(5):429-35. PubMed ID: 23433431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The usefulness of skin tests to prove drug hypersensitivity.
    Lammintausta K; Kortekangas-Savolainen O
    Br J Dermatol; 2005 May; 152(5):968-74. PubMed ID: 15888154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Val/Val glutathione-S-transferase P1 polymorphism predicts nonresponders in psoriasis patients treated with fumaric acid esters.
    Gambichler T; Susok L; Zankl J; Skrygan M
    Pharmacogenet Genomics; 2016 May; 26(5):248-53. PubMed ID: 26967570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organising pneumonia associated with fumaric acid ester treatment for psoriasis.
    Deegan AP; Kirby B; Rogers S; Crotty TB; McDonnell TJ
    Clin Respir J; 2010 Oct; 4(4):248-51. PubMed ID: 20887349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of HCA₂ (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin.
    Hanson J; Gille A; Offermanns S
    Pharmacol Ther; 2012 Oct; 136(1):1-7. PubMed ID: 22743741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS].
    Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF
    Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective data collection of psoriasis treatment with fumaric acid esters in children and adolescents in Germany (KIDS FUTURE study).
    Reich K; Hartl C; Gambichler T; Zschocke I
    J Dtsch Dermatol Ges; 2016 Jan; 14(1):50-8. PubMed ID: 26713639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term use of fumaric acid esters for the treatment of psoriasis in daily practice.
    Termeer C; Reinhold U; Dirschka T; von Kiedrowski R; Kurzen H
    J Dermatolog Treat; 2021 Sep; 32(6):610-616. PubMed ID: 31682772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macular exanthema appearing 5 days after X-ray contrast medium administration.
    Christiansen C; Dreborg S; Pichler WJ; Ekeli H
    Eur Radiol; 2002 Dec; 12 Suppl 3():S94-7. PubMed ID: 12522613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children.
    Zambonino MA; Corzo JL; Muñoz C; Requena G; Ariza A; Mayorga C; Urda A; Blanca M; Torres MJ
    Pediatr Allergy Immunol; 2014 Feb; 25(1):80-7. PubMed ID: 24329898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiocontrast media-associated exanthema: identification of cross-reactivity and tolerability by allergologic testing.
    Seitz CS; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
    Eur J Radiol; 2009 Oct; 72(1):167-71. PubMed ID: 18620831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulation with anisindione in a patient with a warfarin-induced skin eruption.
    Spyropoulos AC; Hayth KA; Jenkins P
    Pharmacotherapy; 2003 Apr; 23(4):533-6. PubMed ID: 12680483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Two cases of side effects of a fumaric acid ester--local therapy].
    Dücker P; Pfeiff B
    Z Hautkr; 1990 Aug; 65(8):734-6. PubMed ID: 2149475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis--a retrospective study (FUTURE).
    Reich K; Thaci D; Mrowietz U; Kamps A; Neureither M; Luger T
    J Dtsch Dermatol Ges; 2009 Jul; 7(7):603-11. PubMed ID: 19459898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.